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Objective: To determine the predictors of cognitive function in patients with drug-resistant 
gelastic seizures (GS) related to hypothalamic hamartoma (HH) before and after stereotactic 
radiofrequency thermocoagulation surgery (SRT).  
Methods: We studied 88 HH patients who underwent SRT between October 1997 and 
December 2014. Patients received neuropsychological tests preoperatively and 
postoperatively. Based on the preoperative measures, patients were categorized as “high-
functioning” (full-scale intelligence quotient [FSIQ] ≥70; n=48) and “low-functioning” group 
(FSIQ <70; n=40). Univariate and multivariate linear regression analyses determined the 
clinical, electroencephalographic (EEG), and imaging factors associated with preoperative 
cognitive function as well as postoperative cognitive change. 
Results: Eighty-seven (98.8%) patients were followed postoperatively for an average of 3.3 
years, and 75 (85.2%) of them achieved GS remission at the last hospital visit. 
Neuropsychological performance was significantly improved after surgery in both groups. 
Multivariate linear regression analysis showed that a smaller HH size (p=0.002) and a smaller 
number of antiepileptic drugs (p<0.001) were preoperatively associated with better 
neuropsychological performance. Multivariate linear regression analysis showed that better 
postoperative improvement in cognition was associated with a shorter duration of epilepsy 
(p=0.03). 
Significance: Cognitive impairment related to epileptic encephalopathy may improve 
following SRT in substantial proportions of HH patients. Reduced improvement in 
postoperative cognitive function in patients with longer duration of epilepsy warrants further 
studies to determine if earlier SRT provides a greater chance of postoperative cognitive 
improvement in patients with HH.  
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INTRODUCTION 
             Hypothalamic hamartoma (HH) is a rare congenital brain lesion.1 Whereas one 
hallmark of HH syndrome is intractable gelastic seizures (GS), about half of HH patients 
exhibit cognitive impairment and behavioral disorders, referred to as epileptic 
encephalopathy.2,3 Both drug-resistant GS and epileptic encephalopathy caused by HH are 
believed to be surgically treatable.2,4 Stereotactic radiofrequency thermocoagulation surgery 
(SRT) is now recognized as an established therapy for intractable GS related to HH;2 
however, the predictors of cognitive profiles before and after SRT remain unclear. Previous 
studies of HH patients who underwent open or gamma knife surgeries reported that 
postoperative cognitive function was associated with several factors, including “anatomical 
features of HH”, “age at epilepsy onset”, “age at surgery”, “duration of epilepsy”, “presence 
of central precocious puberty”, “number of antiepileptic drugs”, and “preoperative cognitive 
function”.5-7 Since relatively small numbers of HH patients were included in the past studies, 
we expected that our longitudinal data derived from a large number of patients uniformly 
undergoing SRT would independently determine the factors predictive of cognitive function 
in patients with HH. Our central hypothesis, based on our clinical practice and the previous 
reports noted above, was that patients with a shorter duration of epilepsy would benefit from 
cognitive improvement following SRT more than those with a longer duration of disease. In 
other words, we hypothesized that the cognitive impairment in patients with severe epileptic 
encephalopathy may be less reversible, even after remission of GS by SRT. Univariate and 
multivariate analyses were employed to determine the clinical, imaging, and 
Au
th
or
 M
an
us
cr
ip
t
Sonoda et al. 5 
 
This article is protected by copyright. All rights reserved 
electroencephalographic factors independently predictive of cognitive function before and 
after SRT. 
    
MATERIALS AND METHODS 
Patient selection 
A total of 127 patients with HH underwent SRT for drug-resistant GS between 
October 1997 and December 2014 in the Hypothalamic Hamartoma Center, Nishi-Niigata 
Chuo National Hospital, Niigata, Japan. The present study included 88 Japanese patients. We 
excluded 39 patients who were unable to undergo the Wechsler Adult Intelligence Scale-
Third Edition (WAIS-III), Wechsler Intelligence Scale for Children-Third Edition (WISC-III), 
or Tanaka-Binet Intelligence Scale (TBIS), because of the presence of severe cognitive deficit 
or because their primary language was other than Japanese. Clinical and neuropsychological 
data at 1 year and at the last hospital visit following SRT were reviewed. One patient was 
followed at another hospital postoperatively. Thereby, the mean follow-up period for 87 
patients was 3.38 years (standard deviation [SD]: 1.8 years). One-year postoperative follow-
up data was available in 84 out of the 87 patients. All patients (or parents of pediatric 
patients) gave written informed consent before presurgical evaluation and surgical treatment. 
 Clinical history and video-electroencephalography (EEG) monitoring characterized 
GS and non-GS type seizures including complex partial seizures, tonic-clonic seizures, 
atypical absence, tonic seizures, atonic seizures, myoclonic seizures, and spasms. Video-EEG, 
recorded with the EEG1100 system (Nihon Kohden, Tokyo, Japan), determined the 
distribution of interictal epileptiform discharges. Preoperative evaluation also included 
neuropsychological tests, ictal/interictal single-photon emission computed tomography 
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(SPECT) with 99mTc-ethyl cysteinate dimer using the Symbia S system (Siemens Japan, 
Tokyo, Japan), and magnetic resonance imaging (MRI) using the Signa HDxt 1.5T system 
(GE Healthcare Japan, Tokyo, Japan). The MRI sequences included a 3D T1-weighted and 
fluid-attenuated inversion recovery images. MRI subtypes were categorized as 
intrahypothalamic, parahypothalamic, or mixed hypothalamic type according to the MRI 
criteria in the previous report.2
 
 
Neuropsychological examination 
A neuropsychologist examined each patient’s cognitive function with WAIS-III, 
WISC-III, or TBIS. In general, patients who were <7 years old were exclusively examined 
with TBIS; patients between 7 and 15 years old were examined with WISC-III, and patients 
≥16 years were examined with WAIS-III. Patients with severe mental retardation who could 
not be examined with WISC-III or WAIS-III were examined with TBIS, even if they were ≥7 
years old. In this study below, “FSIQ” was defined as “full-scale intelligence quotient” on 
WISC-III and WAIS-III or “IQ” on TBIS. “Postoperative cognitive change” was defined as 
subtraction of “preoperative FSIQ” from “FSIQ at 1 year after surgery or at the last hospital 
visit”. The outcome measures of interest included “preoperative FSIQ” and “postoperative 
cognitive change”. 
 
Patient categories  
Based on the result of IQ tests employed preoperatively, patients were categorized 
into “high-functioning” group (FSIQ ≥70; n=48) and “low-functioning” group (FSIQ <70; 
n=40) because mental retardation is defined by the criterion of mental retardation in ICD-10.8 
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Statistical analysis 
Continuous variables were reported as mean and SD, and categorical variables were 
reported as a number and percentage. The two-sample t-test was used to compare the 
distributions of continuous variables (e.g.: clinical profiles such as age) between the two 
patient groups. Fisher’s exact test was used to test the equality of proportions of categorical 
variable (e.g.: gender) between two groups. The paired t-test was used to compare 
distributions in the same patient between two time points (i.e.: before and after surgery). 
Univariate and multivariate linear regression analyses using the variable reduction method 
were performed to determine the factors independently predictive of “preoperative FSIQ” and 
“postoperative cognitive change”.9
 In addition, we determined the factor independently predictive of the verbal 
intelligence quotient (VIQ) and performance intelligence quotient (PIQ) by employing 
regression analyses in patients who were examined with WISC-III and WAIS-III. 
 The predictor variables, incorporated into the regression 
analyses, included: (1) age at onset of GS, (2) duration of GS, (3) duration of non-GS type 
seizures, (4) maximum diameter of HH, and (5) number of antiepileptic drugs (AEDs) before 
surgery. The following categorical variables were also incorporated in the regression model: 
(6) gender, (7) attachment side of HH (bilateral attachment treated as attachment to both left 
and right side), (8) presence of precocious puberty, and (9) presence of preoperative interictal 
scalp EEG interictal epileptiform discharges. In addition to the aforementioned variables, 
(10) preoperative FISQ were also incorporated in the regression model to determine the 
factor independently predictive of “postoperative cognitive change”.  
 Statistical analyses were conducted with EZR (Saitama Medical Center, Jichi Medical 
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University, Saitama, Japan). EZR is a graphical user interface for R (The R Foundation for 
Statistical Computing, Vienna, Austria).10
 
 Statistical significance was set at p <0.05. 
RESULTS 
Patient profiles 
Univariate analyses suggested difference in clinical profiles between the patient 
groups (Table 1). Those in the “high-functioning” group had a shorter duration of non-GS 
than those in the "low-functioning" group (p =0.009; two-sample t-test). Seventy-seven 
patients with HH had non-GS type seizures. The percentage of patients showing interictal 
epileptiform discharges on scalp EEG was significantly higher in the “low-functioning” 
group than in the “high-functioning” group (p =0.005; Fisher’s exact test). Preoperatively, 
patients in the “high-functioning” group took a smaller number of AEDs than those in the 
“low-functioning” group (p=0.006; two-sample t-test). 
 
Preoperative cognitive function and cognitive change following SRT 
Eighty-four patients (95%), including 46 in the “high-functioning” group and 38 in 
the “low-functioning” group, were evaluated at a 1-year follow-up. The mean postoperative 
follow-up period between SRT and the last visit was 3.4 years. FSIQ in each patient group 
was significantly improved postoperatively at 1 year as well as at the last hospital visit (Fig. 
1A and Table 2). Between the groups, there was no significant difference in the degree of 
improvement in FSIQ at postoperative 1 year or at the last visit (Table 2). 
Significant postoperative improvement in FSIQ was noted in those with GS remission 
after SRT (preoperative: 72.8 ± 25.1 vs. postoperative at the last visit: 81.2 ± 26.7; p <0.001; 
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paired t-test) but not in those failing to achieve GS remission (preoperative: 68.8 ± 23.3 vs. 
postoperative at the last visit 71.1 ± 24.1: p=0.36; paired t-test). 
Patients with a history of non-SRT interventions, including partial removal of HH, 
gamma knife surgery, focused resection, corpus callosotomy, and biopsy, had lower 
preoperative FSIQ than those without (no past intervention: 75.7 ± 22.1 vs. with past 
intervention: 62.7 ± 28.9; p=0.03; two-sample t-test). Nonetheless, SRT improved 
postoperative FSIQ even in patients with a previous history of non-SRT interventions 
(preoperative: 62.7 ± 28.9 vs. postoperative at last visit 72.5 ± 31.6; p <0.001; paired t-test). 
There was no difference in the postoperative change in FSIQ between patients with and 
without past non-SRT interventions (past non-SRT interventions 9.9 ± 7.3 vs. no past 
intervention: 6.7 ± 8.8; p=0.13; two-sample t-test). 
 We have provided the detailed results of neuropsychological measures other than 
FSIQ in online supplementary documents (Table S1). 
  
Predictive factors of postoperative cognitive changes  
Univariate linear regression analysis, employed to 84 patients, showed that duration 
of non-GS type seizures (p=0.03) and preoperative number of AEDs (p=0.03) predicted 
postoperative change of FSIQ at 1 year following SRT. These predictor variables were 
negatively correlated to the outcome measure. Multivariate linear regression analysis showed 
that duration of non-GS type seizures (p=0.03) independently predicted postoperative change 
of FSIQ at 1 year following SRT (Table 3).   
 Univariate linear regression analysis, employed to the “high-functioning” group, 
showed that preoperative FSIQ (p=0.04) predicted postoperative change of FSIQ at 1 year 
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following SRT. Multivariate linear regression analysis showed that preoperative FSIQ 
(p=0.01), interictal epileptiform discharges (p=0.04), and mixed hypothalamic type of HH 
(p=0.04) independently predicted the change in FSIQ postoperatively at 1 year. Likewise, the 
postoperative FSIQ change at last visit can be independently predicted by preoperative FSIQ 
(p=0.03) and mixed hypothalamic type of HH (p<0.001) (Table 3).  
Univariate linear regression analysis, employed to the "low-functioning" group, 
showed that preoperative FSIQ (p=0.03), age at onset of GS (p=0.04) and preoperative 
number of AEDs (p=0.04) predicted postoperative FSIQ change at 1 year following SRT. 
Multivariate linear regression analysis showed that duration of non-GS (p=0.007) and age at 
onset of GS (p=0.006) predicted the postoperative FSIQ change at 1 year (Table 3). 
Supplementary Table S2 provides the results of univariate and multivariate linear 
regression analyses to determine the factors independently predictive of the changes in FSIQ, 
VIQ, and PIQ. 
 
Predictive factors associated with preoperative cognitive function  
Univariate linear regression analysis, employed to all 88 patients, showed that 
interictal epileptiform discharges on scalp EEG (p=0.03), intrahypothalamic type of HH 
(p=0.003), mixed hypothalamic type of HH (p=0.02), preoperative number of AEDs 
(p=0.002), maximum HH diameter (p=0.01) and precocious puberty (p=0.04) maintained 
their independent predictive variable status for preoperative FSIQ. Multiple linear regression 
analysis showed that preoperative number of AEDs (p<0.001) and maximum HH diameter 
(p=0.002) predicted preoperative FSIQ (Table 4). These predictor variables were negatively 
correlated to preoperative FSIQ. Univariate linear regression analysis, employed to the "low-
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functioning" group, showed that age at onset of GS (p=0.04) and maximum HH diameter 
(p=0.04) predicted preoperative FSIQ. Multiple linear regression analysis showed that age at 
onset of GS (p=0.006), duration of GS (p=0.04), that of non-GS (p=0.04) and 
intrahypothalamic type of HH (p=0.03) predicted preoperative FSIQ (Table 4).  
 Supplementary Table S3 provides the results of univariate and multivariate linear 
regression analyses, employed to the patients examined with WISC-III and WAIS-III, to 
determine the factors independently predictive of preoperative FSIQ, VIQ, and PIQ. 
 
DISCUSSION 
To our knowledge, this is the first large case-series study to report the changes in 
cognitive function among patients with HH following SRT. Thereby, we determined the 
predictors of postoperative cognitive change. Our findings may help to identify patients with 
HH who are more likely to benefit from SRT in terms of cognitive function, and may also 
help to explain the pathophysiological mechanism of epileptic encephalopathy associated 
with HH. 
 
Predictors of postoperative cognitive changes  
The results of our multivariate regression analyses led to the following hypotheses.  
Ultimately, we hypothesize that early intervention will optimize the degree of postoperative 
cognitive improvement following SRT. The present study provided some evidence that 
warrants early intervention with SRT for intractable GS with HH. First of all, SRT surgery 
improved cognition in patients with a shorter duration of epilepsy more than in those with a 
longer duration (Tables 2 and S2; Fig.1B). Patients with intractable GS related to HH has 
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increased risk of progressive worsening of EEG abnormalities and secondary 
epileptogenesis.11,12 Their academic performance and social skills tend to be impaired by 
such disease progression, similar to patients with childhood-onset temporal lobe epilepsy.13
 We also hypothesize that severe epileptic encephalopathy may be irreversible, even 
after achieving GS freedom (Table 3 and Fig.1C). Our study showed that cognitive function 
of “low-functioning” patients remained lower, even after SRT, than those of “high-
functioning” patients. Among “low-functioning” patients, poor preoperative FSIQ was 
associated with reduced cognitive improvement following SRT (Fig.1A and 1C). In contrast, 
regression analyses, employed to “high-functioning” group alone, revealed that patients with 
lower preoperative FSIQ enjoyed greater cognitive improvement following SRT (Fig. 1A and 
1C). Our observations are consistent with those in previous studies in other institutions. For 
example, Wethe et al. reported that patients with lower preoperative cognition improved 
more than those with higher cognitive function,
  
6
 and their study population can be treated as 
“high-functioning”, based on our study criteria.  Lack of cognitive improvement in patients 
with the most severe cognitive deficit in the “low-functioning” group warrants further studies 
to determine if earlier SRT provides a greater chance of postoperative cognitive improvement 
to the patients with HH. Taken together,14,15
 Patients with interictal epileptiform discharges on scalp EEG had lower preoperative 
cognition than those without interictal epileptiform discharges in the present study. The 
relationship between the severity of cognitive deficit and interictal EEG abnormality has been 
reported by previous studies of HH
 we wish to propose that we should consider early 
intervention for patients with HH before they develop severe and irreversible cognitive 
deficits. 
4,16
 as well as in the other epilepsy 
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syndromes.17,18 Cognitive deficits associated with focal seizures and focal epilepsies may be 
related to the dysfunction of a network of cortical and subcortical brain structures induced by 
epileptic activity.19,20 Among the "high-functioning" patients, the presence of interictal 
epileptiform discharges on scalp EEG was associated with better cognitive improvement 
following SRT. This finding may be attributed to the notion that SRT terminated propagation 
of epileptic discharges from HH to other structures. We previously proposed that the 
mediodorsal nucleus of the thalamus is important for epileptic encephalopathy associated 
with HH because the mediodorsal nucleus of the thalamus has been implicated as the key 
nucleus in intractable GS with HH.21 EEG–functional MRI study in patients with HH also 
supports our hypothesis.22 Schizophrenia and Korsakoff”s syndrome, which are often 
associated with cognitive dysfunction and behavior disorders, also involve dysfunction of the 
mediodorsal thalamus.23,24 The observation that inhibition of the thalamic mediodorsal 
nucleus impairs cognition of animals also supports our hypothesis.25
 
 Further investigation 
into the precise pathophysiological mechanism of epileptic encephalopathy caused by HH is 
needed. 
Clinical change in cognitive function following SRT  
The goal and strategy for patients with intractable GS associated with HH are GS 
remission after SRT and the expectation of cognitive improvement. We believe that freedom 
from GS may be an important key to optimize the cognitive improvement following SRT, 
whereas a previous study reported that postoperative seizure outcome was not necessarily 
associated with postoperative cognitive improvement.6 Univariate analysis, in the present 
study, suggested that failure to achieve GS remission at the last visit was associated with 
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reduced cognitive improvement after SRT. History of past surgical intervention did not 
negatively impact the cognitive improvement following SRT.  
 
Predictors of preoperative cognitive function 
The present study found that larger HHs were associated with poorer preoperative 
cognitive function, as has been previously reported.3 In our previous study, the maximum 
diameter of the HH, once associated with poor preoperative FSIQ (Table 4), was instead a 
positive predictor of postoperative cognitive change in VIQ and PIQ (Table S2). Although 
larger HHs are perceived to be difficult to treat surgically,26 we have a track record of 
successful treatment of giant HH of which diameter is greater than 30 mm.
 In concurrence with our previous report,
27
 
28 
 The use of multiple AEDs is associated with worse cognitive function.
the findings of the current study support the 
classification of HH as being well correlated with preoperative cognitive function. 
Specifically, intrahypothalamic type HH was associated with better intellectual function 
compared to the other types (Tables 4 and S4). We also found that mixed hypothalamic type 
HH was associated not only with lower preoperative cognition but also with lower 
postoperative change of cognitive function (Table 3). 
5
 Most patients 
with GS take multiple AEDs prior to surgery because GS is usually resistant to AEDs.28
 
 We 
hypothesize that early intervention by SRT would reduce the risk of cognitive decline 
attributed to the effects of multiple AEDs. 
 
Limitations 
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The results of this study need to be interpreted in light of several limitations. First, our 
findings were limited to patients who were examined, in Japanese, with WAIS-III, WISC-III, 
or TBIS. Patients who do not speak Japanese (i.e.: most patients from foreign countries) were 
excluded from this study. Second, the outcome measures were derived from the WISC-
III/WAIS-III and IQs from the TBIS and defined them all as “FSIQ.” A previous study 
reported a strong correlation between FSIQ on WISC-III and IQ on TBIS.29 Third, we could 
not exclude a practice effect in long-term follow-up. Therefore, we compared the degree of 
postoperative improvement in the patients with postoperative GS remission vs. those without. 
Although WISC and WAIS are susceptible to practice effects,30 the cognitive improvement in 
our series could not be explained only by practice effects because the degree of cognitive 
improvement was significantly better in patients with GS remission after SRT. Fourth, the 
outcome measures in the present study did not include memory or executive function, which 
might have been positively or negatively altered by epilepsy surgery.6 Memory function was 
measured with the Wechsler Memory Scale only in 31.8% (28/88) of patients; thus, we 
focused on FSIQ in the present study. We plan to collect more pre- and post-operative 
measures on such neuropsychological sub-tests in order to better characterize the effect of 
SRT on cognitive function. Finally, we did not incorporate behavioral disorders as co-
variables, although behavioral disorder is one of the typical symptoms in epileptic 
encephalopathy caused by HH.2,7,31 Further research is clearly needed to enroll participants 
with a definitive behavioral disorder diagnosis, based on the formal assessment to explore the 
relationship between cognitive change after SRT and such disorders.32
 
  
CONCLUSION 
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The main aim of this study was to clarify the predictors that contribute to cognitive 
change following SRT. Cognitive impairment may improve following SRT in substantial 
proportions of HH patients. Patients with longer duration of epilepsy or those with severe 
mental retardation benefited smaller degree of cognitive improvement following SRT. Further 
studies will determine whether earlier SRT provides a greater degree of postoperative 
cognitive improvement in patients with HH. 
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KEY POINTS 
 Patients with intrahypothalamic type HH have better preoperative cognitive function 
 Excessive medication with AEDs affects preoperative FSIQ 
 SRT is effective not only for intractable GS but also for cognitive deficits caused by HH 
 Patients with a shorter duration of epilepsy experience cognitive improvement following 
SRT
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SUPPORTING INFORMATION 
Additional Supporting Information may be found in the online version of this article: 
 Figure S1. (A) Detailed scatter plots of preoperative and postoperative verbal IQ 
(VIQ) and performance IQ (PIQ) in order of preoperative PIQ in individual patients (n=64). 
Black plots show preoperative VIQ or PIQ; gray plots show VIQ or PIQ postoperatively at 
year 1 and white plots show VIQ or PIQ at the last visit after SRT. ◇ = PIQ;  □ = VIQ (B) 
Detailed scatter plots of postoperative change in VIQ in order of preoperative VIQ in 
individual patients (n=64). Gray plots show VIQ postoperatively at year 1 and white plots 
show VIQ at last visit after SRT. ○ = patients with left attachment HH; △ = patients with 
right attachment HH 
 Table S1. Comparison of preoperative vs. postoperative cognitive function in the 
patients examined with WAIS/WISC. 
 Table S2. Predictors of postoperative change in FSIQ, VIQ and PIQ in the patients 
examined with WAIS/WISC by univariate and multivariate linear regression analyses. 
 Table S3. Predictors of preoperative of FSIQ, VIQ and PIQ in the patients examined 
with WAIS/WISC by univariate and multivariate linear regression analyses. 
 Appendix S1. Discussion about VIQ and PIQ in patients who were examined with 
WAIS/WISC. 
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Table 1. Clinical characteristics of patients 
Clinical features All patients 
High-functioning group 
(Preoperative FSIQ≥70) 
Low-functioning group 
(Preoperative FSIQ<70) 
  n=88 n=48 n=40 
  Mean (SD) Mean (SD) Mean (SD) 
Sex, female, n (%) 31 (35) 17 (35) 14 (35)  
Age at surgery, y 16.2 (11.5) 15.3 (11.5) 17.3 (11.5) 
Age at onset of GS/non-GS, y 2.3 (2.8)/6.9 (5.1) 2.6 (3.2)/7.8 (5.4) 2.0 (2.1)/5.9 (4.7) 
Duration of GS/non-GS, y  13.9 (11.1)/8.5 (9.3) 12.7 (11.1)/6.1 (7.9) 15.4 (11.1)/11.3 (10.1) 
Maximum diameter of HH, mm 15.8 (7.1) 14.8 (6.6) 16.9 (7.7) 
Attachment side, n (%), right/bilateral/left 24 (27)/41 (47)/23 (26) 15 (31)/20 (42)/13 (27) 9 (23)/21 (53)/ 10(31) 
MRI subtype, n (%), intra/mixed/para 24 (27)/58 (66)/6 (7) 17 (37)/28(58)/3 (6) 7 (18)/30 (75)/3 (8) 
No interictal epileptiform discharges on scalp EEG, n (%) 12 (14) 11 (23) 1 (3) 
Precocious puberty, n (%) 26 (30) 11 (23) 15 (38) 
Number of preoperative of AEDs, n (%) 2.1 (1.1) 1.7 (1.0) 2.4 (1.0) 
History of non-SRT interventions, n (%) 24 (27) 11 (23) 13 (33) 
Seizure remission, n (%)    
 At POY1: GS/All types of seizure 75 (85)/58 (66) 40 (83)/34 (71) 35 (88)/24 (60) 
 At last visit: GS/All types of seizure 75 (85)/57 (65) 42 (88)/38 (79) 33 (85)/19 (49) 
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Bolded format represents statistically significant findings in comparison between patients in “high-functioning” group and those in “low-
functioning” group (p<0.05). AEDs: antiepileptic drugs. FSIQ: full-scale intelligence quotient. GS: gelastic seizures. HH: hypothalamic 
hamartoma. Intra: intrahypothalamic type. mixed: mixed hypothalamic type. MRI: magnetic resonance imaging. non-GS: non-gelastic seizures 
type seizures. para: parahypothalamic type. POY: postoperative year. PR: partial resection of HH. SD: standard deviation. SRT: stereotactic 
radiofrequency thermocoagulation. 
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Table 2. Comparison of preoperative vs. postoperative FSIQ  
  
Preoperative   
POY1 
n=84 
  
Last visit 
n=87 
  Postoperative change 
    
 
  vs. preoperative 
 
  vs. preoperative 
 
POY1 Last visit 
Group Mean (SD)   Mean (SD) t (df) p value   Mean (SD) t (df) p value   Mean (SD) Mean (SD) 
All patients 72.2 (24.6) 
 
78.6 (25.7) 11.3 (83) <0.001 
 
79.8 (26.5) 8.36 (86) <0.001 
 
6.98 (5.65) 7.61 (8.49) 
High-functioning 90.4 (12.6) a 
 
97.0 (12.1) 8.83 (45) <0.001 
 
98.2 (13.4) 7.02 (47) <0.001 
 
7.07 (5.43) 7.83 (7.73) 
Low-functioning 50.3 (16.4) 
 
56.3 (19.3) 7.07 (37) <0.001 
 
57.2 (20.4) 4.86 (38) <0.001 
 
6.87 (5.99) 7.33 (9.43) 
 
Bolded format represents statistically significant findings in comparison with preoperative cognitive function.  
a
 p <0.05, vs. in the "low-functioning" group 
df, degrees of freedom; FSIQ, full-scale intelligence quotient; IQ, intelligence quotient; POY1, postoperative 1 year; SD, standard deviation
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Table 3. Predictors of postoperative change by univariate and multivariate linear regression analyses  
 Postoperative 1 year 
n=84 
Last visit 
n=88 
 Univariate Multivariate Univariate Multivariate 
Independent variables Reg 
(SE) 
p value Reg 
(SE) 
p value Reg 
(SE) 
p value Reg 
(SE) 
p value 
Female 0.86 
(1.28) 
0.51   0.56 
(1.91) 
0.77   
Age at onset of GS 0.35 
(0.23)  
0.13   0.51 
(0.33) 
0.12   
Duration of GS –0.09 
(0.06) 
0.10   –0.02 
(0.08) 
0.77   
Duration of non-GS –0.14 
(0.07) 
0.03 –0.14 
(0.07) 
0.03 -0.11 
(0.10) 
0.27   
Maximum diameter of HH –0.005 
(0.09)  
0.96   0.02 
(0.13) 
0.85   
MRI subtype      
Intrahypothalamic type 1.02 
(1.41) 
0.47   2.30 
(2.06) 
0.27   
Mixed hypothalamic type –1.67 
(1.32) 
0.21   –3.07 
(1.91) 
0.11   
Parahypothalamic type 3.00 
(2.60)  
0.25   3.64 
(3.59) 
0.31   A
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Attachment side of HH      
 Left side –1.58 
(1.38) 
0.25   –3.65 
(2.01) 
0.07   
 Right side 0.52 
(1.41) 
0.71   2.09 
(2.09) 
0.32   
Interictal interictal epileptiform discharges on sEEG 
 
1.91 
(1.76) 
0.28   –0.06 
(2.65) 
0.98   
Precocious puberty 1.40 
(1.35)  
0.30   1.60 
(1.99) 
0.42   
Number of preoperative AEDs −1.23 
(0.56) 
0.03    –1.40 
(0.84) 
0.10   
Preoperative FSIQ 0.01 
(0.03) 
0.68   0.01 
(0.04) 
0.72   
Constant   8.17     
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Table 3. Continued. 
 High-functioning group 
(Preoperative FSIQ≧70) 
Low-functioning group 
(Preoperative FSIQ<70) 
 Postoperative 1 year 
n=46 
Last visit 
n=48 
Postoperative 1 year 
n=38 
Last visit 
n=40 
 Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate 
Independent 
variables 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Reg 
(SE) 
p 
value 
Female 1.95 
(1.65) 
0.24   3.81 
(2.29) 
0.10   –0.47 
(2.04) 
0.82   –3.42 
(3.14) 
0.28  
 
Age at onset of GS 0.13 
(0.26) 
0.62   0.31 
(0.35) 
0.38   0.90 
(0.44)  
0.04 1.21 
(0.42) 
0.006 1.06 
(0.71) 
0.15  
 
Duration of GS –0.04 
(0.08) 
0.52   0.02 
(0.10) 
0.82   –0.15 
(0.09) 
0.10   –0.08 
(0.14) 
0.59  
 
Duration of non-GS –0.12 
(0.11) 
0.29   –0.08 
(0.14) 
0.56   –0.18 
(0.09) 
 
0.06 –0.24 
(0.09) 
0.007 –0.13 
(0.15) 
0.39  
 
Maximum diameter 
of HH 
–0.09 
(0.12) 
0.45   –0.17 
(0.17) 
0.33   0.08 
(0.13)  
0.55   0.21 
(0.20) 
0.30  
 
MRI subtype         
Intrahypothalamic 
type 
 1.43 
(1.68) 
0.40   5.91 
(2.19) 
0.01   0.16 
(2.70)  
0.95   –5.52 
(4.14) 
0.19  
 
Mixed hypothalamic 
type 
-2.54 
(1.61) 
0.12 –3.11 
(1.49) 
0.04 –6.80 
(2.06) 
0.04 -7.72 
(2.01) 
<0.001 –0.32 
(2.32) 
0.89   3.18 
(3.59) 
0.38  
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Parahypothalamic 
type 
6.73 
(3.84) 
0.09   5.16 
(4.60) 
0.27 
  
0.50 
(3.65)  
0.89   2.17 
(5.73) 
0.71  
 
Attachment side of 
HH 
        
 Left side –1.75 
(1.74) 
0.32   –4.61 
(2.34) 
0.05   –1.34 
(2.31) 
0.57   –2.17 
(3.61) 
0.55  
 
 Right side –0.12 
(1.80) 
0.95   0.93 
(2.53) 
 0.71   1.43 
(2.30)  
0.54   3.76 
(3.58) 
0.30  
 
interictal 
epileptiform 
discharges on sEEG 
 
3.43 
(1.82) 
0.07 3.66 
(1.68) 
0.04 1.55 
(2.67) 
0.56   –8.35 
(5.99) 
0.17   –
11.97(
9.48) 
0.21  
 
Precocious puberty 2.47 
(1.93) 
0.21   0.45 
(2.68) 
0.87   0.66 
(2.01) 
0.75   2.93 
(3.11) 
0.35  
 
Number of 
preoperative AEDs 
–0.80 
(0.76) 
0.31   –0.33 
(1.10) 
0.76   –1.95 
(0.89) 
0.04   –2.83 
(1.41) 
0.05  
 
Preoperative FSIQ -0.13 
(0.06) 
0.04 –0.16 
(0.06) 
0.01 –0.12 
(0.09) 
0.19 -0.18 
(0.08) 
0.03 0.13 
(0.06) 
0.03   0.11 
(0.09) 
0.23  
 
Constant   20.36   28.69   7.19     
 
Bolded format represents statistically significant findings. 
AEDs, preoperative antiepileptic drugs; FSIQ, full-scale intelligence quotient; GS, gelastic seizures; HH, hypothalamic hamartoma; MRI, 
magnetic resonance imaging; non-GS, non-gelastic seizures type seizures; Reg, estimated regression coefficient; SE, standard error; sEEG, scalp 
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Table 4. Predictors of preoperative of FSIQ by univariate and multivariate linear regression analyses 
 
 All patients 
 
n=88 
High-functioning group 
(Preoperative FSIQ≧70) 
n=48 
Low-functioning group 
(Preoperative FSIQ<70) 
n=40 
 
 Univariate Multivariate Univariate Multivariate Univariate Multivariate 
Independent variables Reg 
(SE) 
p value Reg 
(SE) 
p value Reg 
(SE) 
p value Reg 
(SE) 
p value Reg 
(SE) 
p value Reg 
(SE) 
p value 
Female –2.45 
(5.53) 
0.66    –3.31 
(3.80) 
0.39    –1.82 
(5.49) 
0.74   
Age at onset of GS 1.37 
(0.95) 
0.15   –0.12 
(0.57) 
0.83   2.46 
(1.20) 
0.04 3.51 
(1.21) 
0.006 
Duration of GS 0.02 
(0.24) 
0.92   0.27 
(0.16) 
0.11   0.23 
(0.24) 
0.34 1.11 
(0.51) 
0.04 
Duration of non-GS –0.39 
(0.28) 
 
0.17   0.35 
(0.23) 
 
0.13   0.13 
(0.26) 
0.63 –1.23 
(0.58) 
0.04 
Maximum diameter of HH –0.91 
(0.36) 
0.01 –1.08 
(0.34) 
0.002 –0.31 
(0.28) 
0.27 
  −0.69 
(0.33) 
0.04   
MRI subtype       
Intrahypothalamic type 17.30 
(5.63) 
0.003   7.34 
(3.67) 
0.05   11.21 
(6.65) 
0.10 14.04 
(6.20) 
0.03 
Mixed hypothalamic type −12.94 
(5.40) 
0.02   –5.10 
(3.64) 
0.17   –6.77 
(5.95) 
0.26   Au
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Parahypothalamic type −8.23 
(10.44) 
 
0.43   –7.51 
(7.48) 
0.32   −5.04 
(9.91) 
0.61   
Attachment side of HH       
 Left side −8.82 
(5.86) 
0.14   –4.88 
(3.88) 
0.21   –3.88 
(6.24) 
0.54   
 Right side –0.59 
(6.01) 
 
0.92   2.10 
(4.11) 
0.61    –1.57 
(6.05) 
0.80   
Interictal epileptiform discharges on sEEG 
 
−16.59 
(7.49) 
0.03   2.73 
(4.34) 
0.53   –17.10 
(16.55) 
0.31   
Precocious puberty −11.98 
(5.65) 
0.04   –2.02 
(4.35) 
0.64   –7.99 
(5.26) 
0.14   
Number of AEDs –7.41 
(2.34) 
0.002 –8.36 
(2.24) 
< 0.001 –0.06 
(1.79) 
0.97   –4.64 
(2.46) 
0.07 
  
Constant   106.4       37.75 
 
Bolded format represents statistically significant findings.  
AEDs, antiepileptic drugs; FSIQ, full-scale intelligence quotient; GS, gelastic seizures; HH, hypothalamic hamartoma; MRI, magnetic resonance 
imaging; non-GS, non-gelastic seizures type seizures; Reg, estimated regression coefficient; SE, standard error; sEEG, scalp 
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